Glutamate as a Neural Stress Factor in Humans and Animals — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Glutamate as a Neural Stress Factor in Humans and Animals
Veterinary Institute, University Center for Veterinary Medicine, Jagiellonian University, Agricultural University in Cracow, Cracow, Poland
,
Veterinary Institute, University Center for Veterinary Medicine, Jagiellonian University, Agricultural University in Cracow, Cracow, Poland
,
Department of Anatomy and Pathomorphology, University Center for Veterinary Medicine, Jagiellonian University, Agricultural University in Cracow, Cracow, Poland
,
Department of Anatomy and Pathomorphology, University Center for Veterinary Medicine, Jagiellonian University, Agricultural University in Cracow, Cracow, Poland
1 Veterinary Institute, University Center for Veterinary Medicine, Jagiellonian University, Agricultural University in Cracow, Cracow, Poland
2 Veterinary Institute, University Center for Veterinary Medicine, Jagiellonian University, Agricultural University in Cracow, Cracow, Poland
3 Department of Anatomy and Pathomorphology, University Center for Veterinary Medicine, Jagiellonian University, Agricultural University in Cracow, Cracow, Poland
4 Department of Anatomy and Pathomorphology, University Center for Veterinary Medicine, Jagiellonian University, Agricultural University in Cracow, Cracow, Poland
L-glutamic acid (glutamate-Glu) serves as one form with very strong stimulatory neurotransmitter (near aspartic, kainic, alpha-amino-3-hydroxy-5-me- thyl-4-izoxazole propionic acid (AMPA), chinolic and L-homocysteinic acid, glycine and D-serine) at the majority of neural excitatory synapse in the mammals and nonmammals central, sympathetic nervous system (CNS and SNS, respectively) and in different peripheral tissues and organ. It mediates interactions via stimulation a variety ionotropic N-methyl-D-As- partate (NMDA), AMPA and kainate receptors (ligand gated calcium channels) and III groups of the metabotropic glutamate receptors (mGluR 1-8 ) family members (G-protein coupled receptors). It is good known different neuromodula-tion/interaction between Glu and norepinephrine (NE), dopamine (DA), gamma-amino-butyric acid (GABA), oxytocin/vasopressin (Oxy/AVP) and steroid receptors during stress in the central nervous system. In this review we describe the molecular structure of these glutamatergic receptors and discuss they neuropharmacology and clinical use probability of their antagonist, in stress particularly. On the other hand it was interesting if Glu can increase catecholamine (CA) release from motivational structures as stressoric factor in hypothalamo-pituitary adrenal axis (HPA) in the stress inducing processes. Our findings show that Glu more influences the brain’s motivational structure, which may indicate its contribution to the stress response by direct modulating the amount of catecholamine released.
Meldrum, B.S. (2000) Glutamate as a Neurotransmitter in the Brain: Review of Physiology and Pathology. Journal of Nutrition, 130, 1007S-1015S. https://doi.org/10.1093/jn/130.4.1007S
Vyclicky, V., Korinek, M., Smejkalova, T., Balik, A., Krausova, B., Kaniakova, M., Lichnerova, K., Cerny, J., Krusek, J., Dittert, I., Horak, M. and Vyklicky, L. (2014) Structure, Function, and Pharmacology of NMDA Receptor Channels. Physiological Research, 63, S191-S203.
Wolak, M. (2014) Investigation of Ionotropic Glutamate Receptors NMDA an AMPA in the Antidepressive Drugs Mechanism of Action (pol). Ph.D. Thesis, Collegium Medicum in Cracow, Cracow, 10-30.
Permoda-Osip, A. and Rybakowski, J. (2011) The Role of Glutamatergic System in the Mechanism of Antidepressant and Mood-Stabilizing Action in Mood Disorders (pol). Farmakoterapia w Psychiatrii i Neurologii, 2, 57-65.
Peromoda-Osip, A. and Rybakowski, J. (2011) Glutamatergic Conception of Mood Disorders (pol). Psychiatria Polska, 45, 875-888.
Pittenger, C. and Duman, R.S. (2008) Stress, Depression, and Neuraplasticiity: A Convergence of Mechanisms. Neuropsychopharmacology, 33, 88-109. https://doi.org/10.1038/sj.npp.1301574
Pilc, A., Chaki, S., Nowak, G. and Witkin, J.M. (2008) Mood Disorders: Regulation by Metabotropic Glutamate Receptors. Biochemical Pharmacology, 75, 997-1006. https://doi.org/10.1016/j.bcp.2007.09.021
Hunt, D.L. and Castillo, P.E. (2012) Synaptic Plasticity of NMDA Receptors: Mechanisms and Functional Implications. Current Opinion of Neurobiology, 22, 496-508. https://doi.org/10.1016/j.conb.2012.01.007
Du, J., Gray, N.A., Falke, C.A., Chen, W., Yuan, P., Szabo, S.T., Einat, H. and Manji, H.K. (2004) Modulation of Synaptic Plasticity by Antimanic Agents: The Role of AMPA Glutamate Receptor Subunit 1 Synaptic Expression. Journal of Neuroscience, 24, 6578-6589. https://doi.org/10.1523/JNEUROSCI.1258-04.2004
Car, H. (2009) Współdziałanie pomiędzy glutaminianem a kwasem γ-Aminomasłowym w ośrodkowym układzie nerwowym. Neuropsychiatria i Neuropsychologia, 4, 116-125.
Schiffer, H.H. and Heinemann, S.F. (2007) Association of the Human Kainate Receptor GluR7 Gene (GRIK3) with Recurrent Major Depressive Disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 144B, 20-26. https://doi.org/10.1002/ajmg.b.30374
Espey, M.G. and Basile, A.S. (1999) Glutamate Augments Retrovirus Induced Immunodeficiency through Chronic Stimulation of the Hypothalamic-Pituitary- Adrenal Axis. Journal of Immunology, 162, 4998-5002.
Kӧles, L., Kato, E., Hanuska, A., Zádori, Z.S., Al-Khrasoni, M., Zelles, T., Rubini, P. and Illes, P. (2016) Modulation of Excitatory Neurotransmission by Neuronal/Glial Signaling Molecules: Interplay between Purinergic and Glutamatergic Systems. Purinergic Signaling, 12, 1-24. https://doi.org/10.1007/s11302-015-9480-5
Gass, J.T. and Olive, M.F. (2008) Glutamatergic Substrates of Drug Addiction and Alcoholism. Biochemical Pharmacology, 75, 218-265. https://doi.org/10.1016/j.bcp.2007.06.039
Linsambarth, S., Moraga-Amaro, R., Quintana-Donoso, D., Rojas, S. and Stehberg, J. (2017) The Amygdale and Anxiety. In: Ferry, B., Ed., The Amygdale—Where Emotion Shape Perception, Learning and Memories, Neuroscience InTech, 139-171.
Zhang, Z., Li, Y., Zhao, Q., Huang, K., Wang, P. and Yang, P. (2009) First Evidence of Association between G72 and Bipolar Disorder in the Chinese Han Population. Psychiatric Genetics, 19, 151-153.
Dingledine, R., Borges, K., Bowie, D. and Traynelis, S.F. (1999) The Glutamate Receptor Ion Channels. Pharmacological Review, 51, 7-61.
Jin, C. and Woodward, J.J. (2006) Effects of 8 Different NR1 Splice Variants on the Ethanol Inhibition of Recombinant NMDA Receptors. Alcoholism: Clinical and Experimental Research, 30, 673-679.
Walker, R.M., Christoforou, A., Thomson, P.A., McGhee, K.A., Maclean, A.M. and Mühleisen, T.W. (2010) Association Analysis of Neuregulin 1 Candidate Regions in Schizophrenia and Bipolar Disorder. Neuroscience Letters, 478, 9-13. https://doi.org/10.1016/j.neulet.2010.04.056
Łukasik, K., Piotrowska, K. and Pietrzak, B. (2010) The Role of Glutamatergic System in the Pathogenesis and Treatment of Alcohol Dependence (pol). Postępy Higieny i Medycyny Doświadczalnej, 64, 534-543.
Sanacora, G., Zarate, C.A., Krystal, J.H. and Manji, H.K. (2008) Targeting the Glutamatergic System to Develop Novel, Improved Therapeutics for Mood Disorders. Nature Reviews Drug Discovery, 7, 426-437.
Maeng, S. and Zarate, C.A. (2007) The Role of Glutamate in Mood Disorders: Results from the Ketamine in Major Depression Study and the Presumed Cellular Mechanism Underlying Its Antidepressant Effect. Current Psychiatry Reports, 9, 467-474. https://doi.org/10.1007/s11920-007-0063-1
Ninan, I., Bath, K.G., Dagar, K., Perez-Castro, R., Plummer, M.R. and Lees, F.S. (2010) The BDNF Val 66Met Polymorphism Impair NMDA Receptor-Dependent Synaptic Plasticity in the Hippocampus. Journal of Neuroscience, 30, 8866-8870. https://doi.org/10.1523/JNEUROSCI.1405-10.2010
Kawashima, H., Numakawa, F., Adachi, N., Mizuno, H. and Ninomiya, M. (2010) Glucocorticoid Attenuated Brain-Derived Neurotrophic Factor-Dependent Upregulation of Glutamate Receptor via the Suppression of microRNA-132 Expression. Neuroscience, 165, 1301-1311.
Murphy, S.N. and Miller, R.J. (1989) Two Distinct Quisqualate Receptors Regulate Ca2+ Homeostasis in Hippocampal Neurons in Vitro. Molecular Pharmacology, 35, 671-680.
Di Liberto, V., Bonomo, A., Frinchi, M., Belluardo, N. and Mudo, G. (2010) Group II Metabotropic Glutamate Receptor Activation by Agonist LY 379 268 Treatment Increases the Expression of Brain Derived Neurotrophic Factor in the Mouse Brain. Neuroscience, 165, 863-873. https://doi.org/10.1016/j.neuroscience.2009.11.012
Stefansson, H., Sigurdsson, E., Steinhorsdottir, V., Bjornsdottir, S., Sigmundsson, T. and Ghosh, S. (2002) Neuregulin 1 and Susceptibility to Schizophrenia. American Journal of Human Genetic, 71, 877-892. https://doi.org/10.1086/342734
Javitt, D.C., Schoepp, D., Kalivas, P.W., Volkow, N.D., Zarate, C., Merchant, K., Bear, M.F., Umbricht, D., Hajos, M., Potter, W.Z. and Lee, C.M. (2011) Translating Glutamate: From Pathophysiology to Treatment. Science Translational Medicine, 28, 102mr2.
Obrenovitch, T.P. and Urenjak, J. (1997) Altered Glutamatergic Transmission in Neurological Disorders: From High Extracellular Glutamate to Excessive Synaptic Efficacy. Progress in Neurobiology, 51, 39-87. https://doi.org/10.1016/S0301-0082(96)00049-4
Mathew, S.J., Coplan, J.D., Shoepp, D.D., Smith, E.L., Rosenblum, L.A. and Gorman, J.M. (2001) Glutamate-Hypothalamic Pituitary-Adrenal Axis Interactions: Implications for Mood and Anxiety Disorders. CNS Spectrums, 6, 555-556, 561-564. https://doi.org/10.1017/S1092852900002091
Zhuo, M., Wu, G. and Wu, L.J. (2011) Neuronal and Microglial Mechanisms of Neuropathic Pain. Molecular Brain, 4, 31-42. https://doi.org/10.1186/1756-6606-4-31
Bains, J.S., Cusuling, J.I.W. and Inoue, W. (2015) Stress-Related Synaptic Plasticity in the Hypothalamus. Nature Review of Neuroscience, 16, 377-388. https://doi.org/10.1038/nrn3881